December 03, 2024
Inherited SP-B deficiency is an ultra-rare monogenic cause of fatal respiratory distress syndrome in newborn infants with few, if any, options for long-term survival Highly encouraging preclinical data highlight the possibility of lifelong treatment from a single administration of AVG-002 with preparations for clinical...
Continue ReadingJune 07, 2017
CLEVELAND – Harrington Discovery Institute at University Hospitals in Cleveland, Ohio part of The Harrington Project for Discovery & Development, and the Foundation Fighting Blindness have announced their 2017 Gund-Harrington Scholars.Harrington Discovery Institute partnerships are based on a shared mission to advance... Continue Reading
May 27, 2017
From CEOs and politicians to philanthropists and entrepreneurs, Crain’s Who’s Who list is just a snapshot of those making an impact on Northeast Ohio. There were no specific criteria used, but our editorial team huddled and determined which leaders we thought every person doing business in the region should know. Special... Continue Reading
May 24, 2017
Cleveland, Ohio, USA –May 24, 2017 – Harrington Discovery Institute at University Hospitals in Cleveland, Ohio – part of The Harrington Project for Discovery & Development – is pleased to announce its request for proposals for the Harrington Rare Disease Scholar Award. The Harrington Rare Disease Scholar Award supports... Continue Reading
May 04, 2017
CLEVELAND (May 4, 2017) – National and international nominations are being sought for the fifth annual Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application. Deadline for... Continue Reading
May 01, 2017
- 2017 Harrington Scholar-Innovator Continue Reading
May 01, 2017
- 2017 Harrington Scholar-Innovator Continue Reading
May 01, 2017
- 2017 ADDF-Harrington Scholar Continue Reading
April 27, 2017
Takeda and Harrington Discovery Institute at University Hospitals Announce a Collaboration to Advance the Development of Rare Disease TherapeuticsOsaka, Japan and Cleveland, Ohio, USA – 27 April 2017 – Takeda Pharmaceutical Company Limited (TSE: 4502), and Harrington Discovery Institute at University Hospitals in Cleveland... Continue Reading
March 14, 2017
2017 Harrington Prize for Innovation in Medicine Recognizes the Discovery of Incretin Hormones Continue Reading
February 09, 2017
Cleveland, Ohio – Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio – part of The Harrington Project for Discovery & Development – has opened its annual award competition to fund physician-scientist innovators at major academic medical centers across the country to advance their work toward... Continue Reading